JAK inhibitor treatment is not associated with stunted growth in children with common inflammatory diseases, according to a ...
AbbVie to present data from multiple studies of Rinvoq, Humira & Skyrizi at the 2019 ACR/ARP) meeting: North Chicago, Illionis Tuesday, November 5, 2019, 16:00 Hrs [IST] AbbVie, a ...
As AbbVie Inc. ABBV looks to plug holes in the sales of its mega-blockbuster arthritis drug Humira, newer immunology drugs will be key to the pharmaceutical giant’s future growth, analysts say. When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback